Literature DB >> 20636419

Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment.

N Fernández-Hidalgo1, B Almirante, P Tornos, M T González-Alujas, A M Planes, M N Larrosa, A Sambola, A Igual, A Pahissa.   

Abstract

The aims of this study were to compare the characteristics of adult patients with left-sided infective endocarditis (LSIE) diagnosed and treated in a tertiary-care hospital with those of patients referred from a second-level community hospital, and to establish the accuracy of diagnosis and adequacy of treatment in referred patients and the influence of this factor on outcome. A prospective observational cohort study was conducted at Hospital Universitari Vall d'Hebron, a 1000-bed teaching hospital in Barcelona (Spain) and a referral centre for cardiac surgery. One hundred and fourteen of 337 (34%) episodes of LSIE treated in our hospital occurred in transferred patients. As compared with patients diagnosed in our hospital, transferred patients acquired LSIE within the healthcare system less often (16.7% vs. 38.1%, p <0.001), were in better health (Charlson index 3 (interquartile range (IQR)) 1-4) vs. 4 (IQR 2-6), p <0.001), had more complications (94.7% vs. 78.9%, p <0.001), underwent more operations (69.3% vs. 22.1%, p <0.001), and experienced similar mortality (22.8% vs. 31.4%, p 0.100). Only 52 of 114 (45.6%) referred patients received an antimicrobial regimen included in the American, European or Spanish guidelines at the hospital of origin. After adjustment for congestive heart failure and staphylococcal infection in multivariate logistic regression, inadequate or no antimicrobial treatment at origin was a risk factor for in-hospital mortality (OR 3.3, 95% CI 1.1-10.0, p 0.030). Errors in the initial antimicrobial treatment prescribed for LSIE are associated with greater mortality.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20636419     DOI: 10.1111/j.1469-0691.2010.03314.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Risk prediction in infective endocarditis by modified MELD-XI score.

Authors:  Peng-Cheng He; Xue-Biao Wei; Si-Ni Luo; Xiao-Lan Chen; Zu-Hui Ke; Dan-Qing Yu; Ji-Yan Chen; Yuan-Hui Liu; Ning Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-29       Impact factor: 3.267

2.  Association of mean platelet volume level with in-hospital major adverse events in infective endocarditis.

Authors:  Duran Tok; Uğur Canpolat; Derya Tok; Osman Turak; Ahmet İşleyen; Fatih Öksüz; Mehmet Ali Mendi; Kumral Çağlı; Fatma Nurcan Başar; Zehra Gölbaşı
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

3.  Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system.

Authors:  Ugo Fedeli; Elena Schievano; Dora Buonfrate; Giampietro Pellizzer; Paolo Spolaore
Journal:  BMC Infect Dis       Date:  2011-02-23       Impact factor: 3.090

4.  Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospital.

Authors:  A I Peláez Ballesta; E García Vázquez; J Gómez Gómez
Journal:  Rev Esp Quimioter       Date:  2021-11-30       Impact factor: 1.553

5.  Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience.

Authors:  Claudio Ucciferri; Antonio Auricchio; Carmine Cutone; Alessandro Di Gasbarro; Jacopo Vecchiet; Katia Falasca
Journal:  Infect Dis Rep       Date:  2022-03-21

6.  Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

Authors:  Bruno Hoen; Xavier Duval; Guillaume Béraud; Sarah Tubiana; Marie-Line Erpelding; Vincent Le Moing; Catherine Chirouze; Isabelle Gorenne; Pauline Manchon; Pierre Tattevin; Veronique Vernet; Emmanuelle Varon
Journal:  Infect Dis Ther       Date:  2022-05-26

7.  Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study.

Authors:  Lauge Østergaard; Marianne Voldstedlund; Niels Eske Bruun; Henning Bundgaard; Kasper Iversen; Nana Køber; Jens Jørgen Christensen; Flemming Schønning Rosenvinge; Jens Otto Jarløv; Claus Moser; Christian Østergaard Andersen; John Coia; Ea Sofie Marmolin; Kirstine K Søgaard; Lars Lemming; Lars Køber; Emil Loldrup Fosbøl
Journal:  J Am Heart Assoc       Date:  2022-08-10       Impact factor: 6.106

8.  HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.

Authors:  Stephen T Chambers; David Murdoch; Arthur Morris; David Holland; Paul Pappas; Manel Almela; Nuria Fernández-Hidalgo; Benito Almirante; Emilio Bouza; Davide Forno; Ana del Rio; Margaret M Hannan; John Harkness; Zeina A Kanafani; Tahaniyat Lalani; Selwyn Lang; Nigel Raymond; Kerry Read; Tatiana Vinogradova; Christopher W Woods; Dannah Wray; G Ralph Corey; Vivian H Chu
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.